The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.20
Bid: 49.90
Ask: 50.20
Change: 1.60 (3.29%)
Spread: 0.30 (0.601%)
Open: 48.45
High: 51.10
Low: 47.20
Prev. Close: 48.60
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appoints Prof. Clark Chair of ESG Ethics Committee

6 Jul 2020 07:00

RNS Number : 0545S
IP Group PLC
06 July 2020
 

FOR RELEASE ON

 06 July 2020

 

 

IP Group plc appoints Gordon Clark, Emeritus Professor, Oxford University, and long-term investment expert, as Chair of ESG Ethics Committee

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), the developer of intellectual property-based businesses, is pleased to announce that it has appointed Professor Gordon Clark, Senior Consultant and Emeritus Professor of the Smith School of Enterprise and the Environment, Oxford University, as Chair of its Ethics Committee.

 

The Group's Ethics Committee has been set up to oversee IP Group's Ethical Investment Framework which sets out the Group's approach to responsible investing. Professor Clark will Chair the Committee, providing advice on investments when required as well as reviewing the framework and ensuring compliance. The Committee will also comprise a member of the executive team, two partners representing the Group's investment focus areas of life sciences and technology as well as representation from the risk and compliance department. Professor Clark will report to the IP Group plc Board on matters regarding the Ethical Investment Framework and Ethics Committee but is not a Board member.

 

Professor Clark is one of the most influential academics in the world in the field of investment management, particularly in relation to long-term ESG factors such as environmental performance.

 

Alan Aubrey, Chief Executive of IP Group plc and Board representative for ESG, said: "Responsible investing has long been at the heart of IP Group's ethos, as we aim to address some of the world's most pressing challenges and generate positive social and environmental impact alongside financial returns. We are very pleased to have Professor Clark working with IP Group as we formalise our approach to responsible investment. The recent COVID-19 outbreak has further brought to light the role of investors and companies in ensuring best practice in environmental, social and governance issues. Professor Clark has an excellent insight into this subject and we look forward to working with him."

 

Professor Clark said: "I look forward to working with IP Group on its ESG and ethics initiative. It's a remarkable time, of course, with the COVID-19 challenge and the issue of climate change - two particularly pressing and substantial issues, which both investors and the public are increasingly vocal about. I am pleased to be part of IP Group's work and contributing to a better understanding of the role that the company can play in addressing these issues."

 

As well as serving as a Professorial Fellow at St Edmund Hall, Oxford, Professor Clark is also co-Director of the Zurich-Oxford research programme at the Smith School of Enterprise and the Environment. He has been Sir Louis Matheson Distinguished Visiting Professor at Monash University's Faculty of Business and Economics (Melbourne) and is currently a Visiting Scholar at Stanford University's Global Projects Centre (part of the Faculty of Engineering). 

 

IP Group aims to address some of the world's most pressing challenges through the companies and innovation we back and support, allowing us to generate positive social and environmental impact alongside financial returns.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

Ashleigh Lezard

+44 (0) 7979 853802

+44 (0) 7920 510065

Charlotte Street Partners

 

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAKKPBQPBKDFOK
Date   Source Headline
24th Oct 20226:02 pmRNSHolding(s) in Company
14th Oct 20229:42 amRNSHolding(s) in Company
30th Sep 202210:39 amRNSTotal Voting Rights
21st Sep 20225:29 pmRNSHolding(s) in Company
20th Sep 20226:10 pmRNSDirector/PDMR Shareholding
15th Sep 20224:41 pmRNSInvestor presentation
14th Sep 20224:33 pmRNSFurther re Scrip Dividend
13th Sep 20226:00 pmRNSFurther re Interim Scrip Dividend
13th Sep 20227:01 amEQSIP Group Trust (IPO): Initiation — International investor in impactful innovation
7th Sep 20224:33 pmRNSDirector/PDMR Shareholding, SAYE scheme
31st Aug 20228:51 amRNSIstesso starts Phase 2b trial of MBS2320
30th Aug 202212:59 pmRNSCash acquisition of portfolio company Diurnal
18th Aug 20229:25 amRNSScrip Dividend Reference Price
11th Aug 202210:50 amRNSHolding(s) in Company
3rd Aug 20227:00 amRNSHalf-yearly results
2nd Aug 20227:00 amRNSPortfolio company Hysata completes funding round
13th Jul 20229:30 amRNSNotice of Results
30th Jun 20225:46 pmRNSRSP awards and Scrip Elections
29th Jun 20229:16 amRNSFurther re Scrip Dividend
22nd Jun 20227:00 amRNSLaunches ‘Kiko Ventures’ cleantech platform
16th Jun 202211:27 amRNSDirector/PDMR Shareholding
14th Jun 20227:00 amRNSAGM Statement
8th Jun 20227:30 amRNSTR-1
6th Jun 20228:14 amRNSScrip Dividend Reference Price
1st Jun 20223:23 pmRNSInvestor presentation; AGM arrangements
13th May 202212:43 pmRNSDirector Declaration
9th May 20225:21 pmRNSNotice of AGM, Annual Report
29th Apr 20223:46 pmRNSTotal Voting Rights
27th Apr 20226:16 pmRNSDirector/PDMR Shareholding
25th Apr 20226:09 pmRNSDBSP awards; Director/PDMR shareholding
5th Apr 20227:00 amRNSPortfolio company First Light achieves fusion
16th Mar 20227:00 amRNSAnnual Results
7th Mar 20228:00 amRNSPortfolio co Microbiotica completes £50m raise
2nd Mar 20229:19 amRNSNotice of Results
14th Feb 20227:00 amRNSPortfolio company Bramble raises £35m
14th Feb 20227:00 amRNSPortfolio co First Light completes $45m fund raise
28th Jan 20225:02 pmRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
27th Jan 20227:00 amRNSTransaction in Own Shares
25th Jan 20225:45 pmRNSHolding(s) in Company
25th Jan 20225:39 pmRNSTransaction in Own Shares
24th Jan 20225:58 pmRNSTransaction in Own Shares
24th Jan 20227:00 amRNSTransaction in Own Shares
20th Jan 20225:52 pmRNSTransaction in Own Shares
19th Jan 20226:12 pmRNSTransaction in Own Shares
18th Jan 20225:52 pmRNSTransaction in Own Shares
18th Jan 20221:00 pmRNSHolding(s) in Company
18th Jan 20227:00 amRNSTransaction in Own Shares
14th Jan 20226:13 pmRNSTransaction in Own Shares
13th Jan 20226:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.